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Abstract 
 
 A murine line haploinsufficient in the cardiac sodium channel has been used to model 
human Brugada syndrome: a disease causing sudden cardiac death due to lethal ventricular 
arrhythmias. We explored the effects of cholinergic tone on electrophysiological parameters 
in wild type and genetically modified, heterozygous, Scn5a+/- knockout mice. Scn5a+/- 
ventricular slices showed longer refractory periods than wild-type both at baseline and during 
isoprenaline challenge. Scn5a+/- hearts also showed lower conduction velocities and 
increased mean increase in delay than did littermate controls at baseline and blunted 
responses to isoprenaline challenge. Carbachol exerted limited effects but reversed the effects 
of isoprenaline with co-application. Scn5a+/- mice showed a reduction in conduction reserve 
in that isoprenaline no longer increased conduction velocity and this was not antagonised by 
muscarinic agonists.   
 
Key Words: autonomic nervous system, conduction, SCN5A haploinsufficiency, Brugada 
syndrome 
 
Abbreviations: MEA – multielectrode array, VERP – ventricular refractory period, Scn5a+/- 
– cardiac sodium channel (Scn5a) haploinsufficient mouse 
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Introduction 
  
 Brugada Syndrome is recognised by a triad of right bundle branch block, coved ST 
elevation in the right precordial leads and lethal ventricular arrhythmias (6; 25). It may be 
responsible for up to a fifth of cases of sudden cardiac death in the young (25). Where a 
mutation is identified this most commonly occurs in the main cardiac sodium channel 
isoform, SCN5A (4) though in many patients no obvious mutations are found. The main 
pathophysiological feature is the presence of significant cardiac conduction delays 
particularly in the right ventricular outflow tract and these contribute to the ECG pattern and 
arrhythmic predisposition (15). Furthermore, it is well known that sodium channel density is 
an important determinant of conduction velocity in the heart (14).  
 An interesting feature of Brugada Syndrome is that ventricular arrhythmia occurs at 
night when the patient is sleeping and this can be accompanied by accentuation of the 
characteristic ECG pattern (21; 23). The autonomic nervous system is well known to 
modulate ventricular excitability; however in many other channelopathies it is exercise or 
stress that precipitates ventricular tachycardia and/or fibrillation and thus this observation is 
intriguing (9). During rest, vagal activity is predominant in contrast to the situation in 
exercise where vagal activity is reduced and sympathetic drive predominates though the 
detailed picture may be more complex than this standard interpretation (18). In this study, we 
explore this question in a model of Brugada Syndrome namely the SCN5A- haploinsufficient 
mouse (Scn5a+/-). This model recapitulates a number of the features of Brugada syndrome 
seen in patients (11; 12; 19; 24) and provides a route to exploring the autonomic modulation 
of the electrophysiological substrate. 
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Methods 
 
Murine breeding and genotyping 
 Mice were maintained in an animal core facility under UK Home Office guidelines 
relating to animal welfare. All mice were kept in individually ventilated, pathogen-free, 
temperature controlled cages (21-23ºC) with 12-hour day/night light cycles. Animals had free 
access to standard rodent chow and water.  Mice of both sexes were studied between 12 and 
24 weeks of age under standardized conditions for tissue slice analysis. Whole heart studies 
were performed at between 9 months and 1 year of age in mice of both sexes. The generation 
of the Scn5a+/- heterozygotic mice has been previously described (24). Genotyping was 
performed at 6 weeks of age. Littermate controls were used throughout, and experiments and 
analysis were performed blinded to genotype (MF, VV). The work was carried out under UK 
Home Office project licences PPL-6732 and PPL-7665.  
 
Cardiac Excision 
 Mice were euthanized by cervical dislocation. The thorax was immediately dissected 
and the heart exposed. Cardioplegia was induced by applying 10 ml of ice-cold, oxygenated 
(bubbled with 95% O2; 5% CO2) Ca
2+-free Krebs solution (119 mM NaCl, 4 mM KCl, 1 mM 
MgCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, 10 mM glucose, 2 mM Na pyruvate, pH 7.4) 
directly onto the epicardial surface. The heart and great vessels were removed within 20 sec 
and placed into a dissection dish containing oxygenated ice-cold Ca2+-free Krebs solution. A 
23 gauge cannula was inserted into the aorta and secured under light microscopy. For tissue 
slicing, cold retrograde perfusion was commenced with oxygenated, ice-cold, Ca2+ free Krebs 
solution at a flow rate of 16.5 ml/min. Whole-heart recording perfusion used oxygenated 
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Krebs solution (containing 1.4 mM Ca2+) at room temperature. The time taken from cervical 
dislocation to establishment of Langendorff perfusion was less than 3 min.  
 
Preparation of cardiac tissue slices 
 Following perfusion for 2 min, the perfusate was altered to an ice-cold oxygenated 
Ca2+-free Krebs solution containing high K+ (20 mM KCl) and blebbistatin (20 µM; 
Cambridge Bioscience, Cambs, UK) for 3 minutes. The hearts were then removed from the 
Langendorff perfusion rig and placed again in a dissection dish containing cold perfusate. 
Ventricular tissue was dissected from atrial tissue under light microscopy. The dissected 
ventricles were then embedded in low-melt agarose (4% low-melting point agarose in Ca2+-
free Krebs solution), and then rapidly chilled on ice. The agarose block was orientated and 
fixed onto a magnetic stage using cyanoacrylate glue and placed in the cutting chamber of a 
Vibratome (Campden Instruments, London, UK). This chamber was maintained at 4ºC using 
external ice. It was filled with cold, modified oxygenated Krebs solution (containing 0.6 mM 
Ca2+, 10 mM K+). Tissue sections were obtained from apex to base at an interval thickness of 
200 µm. The vibrating PTFE-coated steel blade (Wilkinson Sword, Bucks, UK) was 
advanced at <200 µm/sec. The x-axis vibration was applied at an amplitude of 2 mm and 
frequency of 80 Hz. The z-axis deviation was calibrated prior to every use to be < 1µm.  The 
cut sections were immediately placed in oxygenated low-Ca2+ Krebs solution (4 mM KCl, 0.6 
mM Ca2+) containing 10 mM blebbistatin maintained at room temperature. After 25 minutes, 
the samples were transferred to standard oxygenated Krebs solution (4 mM KCl, 1.1 mM 
Ca2+) and kept at room temperature until electrophysiological studies were performed. 
 
Cardiac slice electrophysiological (EP) studies 
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 Stimulation was generated by a stimulus isolation unit (DS-2A, Warner Instruments, 
MA, USA) with signal timing driven by an Arduino Uno microcontroller (Arduino, It). 
Stimulation was applied using a silver chloride bipolar electrode. The sections were placed in 
the recording chamber and carefully positioned manually so that left ventricular tissue 
overlaid the measurement electrodes. A 1 cm diameter metal ring with an overlying nylon 
mesh (Harp-slice grid, Micro Control Instruments, East Sussex, UK) was used to hold the 
tissue flat in place on the electrode grid and ensured adequate tissue electrode contact. The 
recording chamber was mounted in the headstage and perfusion commenced at 2 ml/min. 
Tissue was allowed to settle to a steady state over 1 min before electrode placement. The 
bipolar stimulating electrode was carefully lowered to just contact the tissue slice on the left 
ventricular tissue, but not to move the slice on the array. Stimulation was started at a 
frequency of 5 Hz using a monophasic 1 ms duration pulse, for real-time recording of 
electrical activity. The stimulus voltage was increased until electrical capture was achieved. 
The stimulus voltage was then reduced until electrical capture was lost: the lowest voltage 
stimulus that could reliably achieve capture was then taken as the stimulus threshold. Cardiac 
signals were recorded at a sampling frequency of 10 kHz. A simulation protocol was 
performed with steady state pacing at an interstimulus interval of 200 ms, with stimulation 
during recording applied at an amplitude of twice threshold. Around 30 sec of pacing activity 
were recorded for each state for each slice. Perfusate solution containing drugs was washed in 
over 30 seconds at 20 ml/min. Slices were then stimulated at 5 Hz for 2 min before threshold 
was determined and recording commenced. 
 
Ex-vivo whole heart recordings 
 For whole heart recordings, hearts were retrogradely perfused at 16.5 ml/min with 
normal oxygenated Krebs solution (Ca2+ 1.4 mM). A unipolar silver chloride stimulation 
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electrode and flexible 32-pole multi-electrode array (MEA) (FlexMEA, Multielectrode 
Systems) were placed on the ventricular epicardium and an S1S2 decremental stimulation 
protocol was performed to determine the ventricular effective refractory period (VERP). 
Stimulation was performed with a biphasic pulse of amplitude 2 V and duration 0.5 ms, with 
S1S2 intervals reduced from 150 ms by decrements of 5 ms to 100 ms and thereafter by 
decrements of 2 ms until tissue refractoriness was reached. Arrhythmogenicity was further 
tested for by applying stimulating trains of 100 beats at coupling intervals progressively 
reduced from 100 ms. Ventricular tachycardia was defined as a ventricular arrhythmia 
persisting more than 2 sec.  
 
Analysis of electrograms 
 All analysis of murine electrophysiology was performed using custom software 
running in Matlab, v2014b (The Mathworks Inc., MA, USA). The time point of local 
activation was taken at the steepest negative gradient of the unipolar electrogram. Conduction 
velocities were determined using a gradient method, with conduction velocity defined as the 
inverse of the gradient in activation times across the array (Figure 1A-C). Electrodes with 
significant noise were excluded, and all electrograms and time points were checked manually. 
Mean increase in delay (MID), a well-validated measure of inducibility of conduction delay, 
was calculated by determining the area under the conduction-delay curve (15) and according 
to the equation  
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Where MID is Mean Increase in Delay, S1 CI is the coupling interval of steady state pacing 
(S1) and minS2 CI is the minimum coupling interval above ERP. The integral was calculated 
using the trapz function in Matlab. 
 The mean timing of the activation time of all recording electrodes was used for each 
measurement of conduction delay, and the MID defined as the unit increase in conduction 
delay per unit reduction in S1S2 coupling interval (ms/ms). Stimulation protocols were 
performed in normal Kreb’s solution, in baseline (control) conditions or with isoprenaline 
100 nM and/or carbachol 10 µM. 
 
Immunofluorescence of cardiac sections 
 Mouse hearts were rinsed in PBS and cut longitudinally with a blade and tissue 
holder.  The hearts were fixed in 10% formalin (Sigma) for at least 24 hours followed by two 
PBS washes and stored in 70% ethanol before paraffin embedding.  Paraffin-embedded hearts 
were cut to 5 m thick sections and mounted on Superfrost plus microscope slides.  Sections 
were then deparaffinized with xylene and rehydrated with 4 ethanol washes (from 100%-
50%) before heat-mediated antigen retrieval with citrate buffer (pH 6.0).  Following antigen 
retrieval, sections were washed several times in PBS, permeabilized with 0.1% Triton X-100 
for 15 minutes and blocked with 5% goat serum in PBS for 1 hour at room temperature.  
Sections were then incubated with primary antibodies with 1% goat serum overnight at 4°C:  
Mouse monoclonal Cx43 clone 4E6.2 (Millipore MAB3067) and rabbit polyclonal N 
cadherin antibody (Santa Cruz SC-7939).  The sections were incubated with fluorescently 
labelled secondary antibodies Alexa Fluor goat anti-mouse 488 and goat anti-rabbit 555 
secondary antibodies (Invitrogen, UK) for 1 hour at room temperature in the dark.  Sections 
were washed several times with PBS and co-stained with DAPI (nuclear stain) and stored in 
the dark until further analysis.  The samples were analyzed using confocal microscopy (LSM 
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510, Carl Zeiss with DAPI: Excitation 405 nm, Emission  LP420, FITC:  Excitation 488 
nm, Emission  BP 505-550 and Cy3: Excitation 543 nm, Emission  LP 560. Images were 
acquired sequentially. Quantitative analysis of the images was performed using ImageJ. 
Thresholding was applied to the images and they were then converted to binary files. The 
Cx43 stained image was subtracted by the N-cadherin stained image and represented “Cx43 
not located at the intercalated disk”.  
 
Statistical analysis 
 All statistical analysis was performed using R software (The Comprehensive R 
Archive Network (CRAN)). Continuous parametric data are presented as means ± standard 
deviations (SD) or, in the case of significance derived from regression models, mean with 
[95% confidence interval], unless otherwise specified. Comparisons in which a single 
measurement was taken for each subject, e.g. ventricular effective refractory period (VERP), 
dispersion of repolarisation time, were made using Student’s t-test with post-hoc correction 
for multiple comparisons. Continuous parametric data derived from electrogram data were 
modelled using mixed-effects linear regression (software: Linear and Nonlinear Mixed 
Effects (NLME) package running in R version 2.14) and statistical significance was inferred 
from the model. Quartile regression with bootstrapping (Quantile Regression Description 
Estimation and inference (QUANTREG) package) was used to compare non-parametric 
continuous data. Statistical significance is indicated by *p<0.05, **p<0.01 and ***p<0.001. 
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Results 
  
 There are conflicting reports of the effects of autonomic modulation on 
electrophysiological parameters in ventricular tissue such as conduction velocity (7). We 
accordingly investigated the effects of autonomic challenge on indices representing activation 
and recovery in littermate normal murine hearts and Scn5a-haploinsufficient heterozygous 
(Scn5a+/-) mice. We used two approaches to examine tissue level electrophysiology: tissue 
slices from juvenile animals (aged 2-3 months) placed on a MEA system, and ex-vivo 
Langendorff perfused hearts from mature animals (aged 9 months to a year) studied using an 
externally applied electrode array. Previous studies in older Langendorff perfused hearts had 
associated arrhythmic phenotypes with the Scn5a+/- genotype but we were unable to obtain 
viable tissue slices from older animals for multi-electrode array studies. We applied 
isoprenaline as a β-adrenoreceptor activator to mimic sympathetic activation and the 
muscarinic receptor agonist carbachol, to approximate vagal activation.  
 Ventricular slices obtained from juvenile Scn5a+/- mice required higher stimulus 
voltages than did wildtype (4.0 ± 0.7 vs 2.7 ± 0.4 V at baseline, **) for consistent capture, 
both before, and following all the different pharmacological manipulations. Untreated slices 
from Scn5a+/-  hearts showed a trend towards lower conduction velocities than WT hearts 
(0.31 ± 0.04 vs 0.40 ± 0.7 m/s), but this was not statistically significant. Isoprenaline (100 
nM) challenge increased conduction velocity in slices from wildtype (0.58 ± 0.11 m/s) but 
not in Scn5a+/- heart slices (0.34 ± 0.05 m/s) *. The increase in conduction velocity was 
reversed with carbachol co-application (Figure 2). Tissue slices from Scn5a+/- hearts showed 
consistently longer effective refractory periods both before (means ± SEM: Scn5a+/- 79 ± 4 
vs WT 63 ± 4 ms, ***) and during isoprenaline challenge (73 ± 7 vs 52 ± 7 ms). Carbachol 
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markedly shortened the VERP in slices from WT but not Scn5a+/- hearts (Scn5a+/-: 76±7 
ms, WT: 41±5 ms **).  
 In Langendorff-perfused isolated hearts, S1S2 decremental protocols were attempted 
before pharmacological challenge, and in the presence of isoprenaline 100 nM, and/or 
carbachol 10 µM. However, pacing capture became inconsistent during carbachol 
administration in 6 out of 8 Scn5a+/- hearts, despite attempts at increasing stimulation 
amplitude. Data from Langendorff-perfused Scn5a+/- hearts were therefore formally 
analysed for isoprenaline effects only (n=11) and were compared to littermate WT hearts 
(n=10).  Washout (5 mins) was performed between drug challenges. Scn5a+/- hearts showed 
blunted responses to isoprenaline, mimicking the data from the cardiac tissue slice 
preparations (Figure 3).  Notably, a 16% increase in conduction velocity observed in WT 
hearts in response to isoprenaline was again blunted in Scn5a+/- hearts (normalised 
conduction velocity control vs Scn5a -/- response to isoprenaline **), which exhibited a 
marginal decrease in conduction velocity. No consistent changes in electrophysiological 
parameters were observed during carbachol administration in the WT group. 
 Induced conduction delay in response to premature extrastimuli was also investigated. 
Mean increase in delay was almost double in Scn5a+/- hearts compared to WT controls 
(***).  Controls and Scn5a+/- murine hearts studied through these procedures did not show 
differences in arrhythmia inducibility under control conditions, or isoprenaline 100 nM or 
carbachol 10 µM challenge (arrhythmic phenomena shown in 1/7 hearts in both drug 
challenges, with no sustained arrhythmias in either Scn5a -/+ or controls).  Little consistent 
change in VERP with drug challenge was observed in whole heart preparations (Figure 3C). 
 Finally we investigated a possible relationship between haploinsufficiency of Scn5a 
and the localization and expression of Cx43 in the juvenile animals. The expression of Cx43 
was not grossly changed but there was an impression of localisation away from the 
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intercalated disc (marked by N-Cadherin staining) and into the cytosol (Figure 4). We 
confirmed this by quantifying the redistribution as detailed in the Methods.  We expressed the 
localisation as a ratio of the amount of Cx43 not at the intercalated divided by the total 
expression of Cx43. In wildtype mice this number was 53.7 ± 3.9% and in Scn5a+/- mice 
71.6% ± 2.7% (n=5 both groups, P<0.01). 
 13
Discussion 
  
 In this study we have investigated the tissue level electrophysiological properties of 
ventricles from Scn5a haploinsufficient mice and compared these to littermate controls. Our 
main finding is that there is an impairment of the response of conduction velocity to 
autonomic challenge in Scn5a+/- mice. In hearts from control mice, isoproterenol increased 
conduction velocity and decreased mean propagation delays. Scn5a+/- hearts demonstrated a 
reduced response of conduction velocity with increased mean propagation delays in response 
to isoprenaline. This effect was reversed by further challenge with carbachol, a muscarinic 
agonist although carbachol alone did not have prominent effects. This is consistent with 
previous reports that sympathetic activation increases conduction velocity in normal hearts (2; 
7). In heart slice preparations in juvenile animals, ERP was prolonged in Scn5a+/- hearts 
whilst in older animals there was no significant difference when studied in Langendorff 
perfused intact hearts. 
 The findings in murine hearts may correlate with previous reports that β-
adrenoreceptor activation increases sodium currents and therefore action potential conduction 
velocity through a protein kinase A dependent mechanism (20); reduced effects of 
isoprenaline could then be associated with the Na+ channel haploinsufficiency in Scn5a+/- 
hearts. There is also the possibility that signalling pathways downstream of the β- adrenergic 
signalling pathway may also modulate gap junction density at the intercalated disc (7; 16).
 
We also saw a potential mislocalization of Cx43 away from the intercalated disk in sodium 
channel haploinsufficient mice and this may contribute to the conduction slowing. It is 
plausible that some form of interaction with scaffolding or other proteins may be responsible 
for maintaining stoichiometry of Cx43 and Scn5a at the intercalated disk. A number of 
interacting sodium channel proteins are known and Cx43 can influence the trafficking of 
Scn5a (1; 27). This is a topic for investigation in future studies. We did not see prominent 
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responses to carbachol in tissue level electrophysiological parameters after washout of 
isoprenaline. However, combined application of both isoprenaline and carbachol in wildtype 
tissue slices reversed the effect of isoprenaline on conduction velocity. This likely involves 
receptor activation of M2 muscarinic receptors coupled to inhibitory G-proteins that directly 
antagonise the response at the level of adenylate cyclase (10). The Gi2 isoform seems to be 
central to muscarinic receptor signalling: L-type calcium channel modulation in ventricular 
myocytes is known to be abolished in Gi2 knockout mice (8). The slow conduction may be 
pro-arrhythmic through promotion of re-entry and wavebreak. Importantly, the increases in 
MID observed in Scn5a+/- hearts provide evidence of the propensity for this group to have 
greater induced (rather than fixed) conduction velocity slowing. The implication therefore is 
that the consistency of conduction may become destablised when challenged by premature 
extrastimuli in the context of autonomic modulation; whilst in the steady-state or resting 
condition these hearts exhibit conduction velocity dynamics similar to those in wild-type 
littermates. 
The marked differences in baseline conduction velocities between the tissue slice 
preparations and the whole heart Langendorff preparations may result from the involved 
tissue preparation techniques required to obtain viable slices. Even limited tissue disruptions 
that may have occurred during slice preparation could lead to reductions in cell-to-cell 
coupling, and thus accentuate pre-existing conduction delays.  
 In understanding the human Brugada syndrome two main hypotheses have been 
advanced (3; 15; 22): either that conduction is slowed and thus activation delayed or that 
repolarisation occurs prematurely.  More specifically, coved ST segment elevation in ECG 
leads V1-V3, often taken as the hallmark of the syndrome, equates to either delayed 
depolarisation from the RV body to the RVOT or a shortened action potential in the 
epicardium leading to repolarisation gradients across the right ventricular wall. The present 
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findings in this mouse model show that autonomic activation has the potential to significantly 
modulate conduction delays, particularly in the context of pre-existing conduction deficiency.  
Our major finding is that adrenergic increases in conduction velocity are impaired in the 
Scn5a+/- mouse. This process in the normal murine heart is antagonised by muscarinic 
receptor activation but lost in the sodium channel haploinsufficient mouse. In the intact 
animal there will be a degree of autonomic balance and even at rest vagal tone will be 
modified by a degree of sympathetic drive. The absolute slowing may then be greatest when 
high vagal tone is combined with cardiac sodium channel haploinsufficiency. We have 
recently completed a study in man examining the effects of edrophonium on endocardial and 
epicardial right ventricular electrophysiology (5). We demonstrated that edrophonium 
appears to modulate both conduction and repolarisation in patients with BrS, particularly 
delaying activation and repolarisation in the right ventricular epicardium, in line with these 
presented results.  
 Though the use of isolated tissue from transgenic mice permits study of tissue-level 
phenomena, this approach does have limitations which are reflected in this study. The 
relatively small anatomy and thin ventricular walls did not permit detailed examination of 
differential epicardial and endocardial characteristics or selective studies of the right 
ventricular outflow tract. However with some adaptation of the array technology this may be 
possible in the future. In a previous study, only a trend to an increase in conduction velocity 
with isoprenaline was observed which did not reach statistical significance. (17). Variations 
in animal lines may explain such variance. Sodium channel mutations leading to phenotypic 
disease can occur in families where BrS is inherited in an autosomal dominant fashion. In 
general these mutations lead to a loss of sodium channel function and the disease is generated 
by SCN5A haploinsufficiency (13; 26). However in the majority of patients no mutation is 
obvious, the disease occurs sporadically and may have a different pathogenesis (13; 26). 
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Caution must therefore be exercised in applying the results of animal studies to this human 
syndrome. 
 In conclusion we have examined the influence of autonomic regulation on tissue level 
cardiac electrophysiology in a mouse model of BrS. Haploinsufficiency of Scn5a leads to 
impairment of conduction velocity reserve with blunting of sympathetically mediated 
increases and reversal by muscarinic receptor activation compared to littermate control mice.  
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Figure Legends 
 
Figure 1. Measurement of conduction velocity and Mean Increase in Delay from 
multielectrode array. A. An example electrogram from a single electrode of a multielectrode 
array is shown. The local activation time is taken as the dV/dt min(arrow), during calculation 
the pacing artefact is blanked. B. Each electrogram and activation time is assigned to a 2D 
coordinate on a grid reflecting the geometry of the multielectrode array. Local activation time 
is determined for all the electrodes on the grid. Electrode numbers are given as E1, E2 etc. C. 
The gradient of activation times is then determined by interpolation (shown as a colourmap). 
The inverse of this “activation time gradient” can be determined to give the conduction 
velocity. The median conduction velocity over the multielectrode array was used for 
measurement. D. Determination of Mean Increase in Delay.  The activation time is plotted for 
a series of S1S2 coupling intervals. The mean change in activation time over this interval (the 
Mean Increase in Delay, MID) is calculated by determining the area of the activation time 
change with coupling interval change (shaded area in figure). This area is divided by the 
Change in Coupling Interval to give the unit Mean Increase in Delay. The MID allows the 
susceptibility to conduction slowing with coupling interval changes to be compared.  
   
Figure 2. Murine tissue slice conduction velocity (CV) measurements. A. Light 
microscope image of ventricular slice section on multielectrode array. B. Example 
electrograms acquired from WT and Scn5a+/- mice hearts under baseline and isoprenaline 
challenge. C. The effects of isoprenaline (Iso) and the ACh agonist carbachol (Carb) are 
shown in the 2 murine groups. A significant increase in CV is seen in response to isoprenaline 
which is absent in the Scn5a+/-  mice. This effect is abolished by carbachol. Asterisks indicate 
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statistical significances from comparisons between Scn5a+/- and wild type (** p<0.01, 
***p<0.001).  
 
Figure 3. Electrophysiological properties of Langendorff-perfused hearts from Scn5a+/- 
and wild type mice under isoprenaline challenge. A. Conduction velocity dynamics 
mirrored those seen in tissue slice preparations, with paradoxical responses to isoprenaline 
challenge in the heterozygous mouse hearts. The MID of Scn5a+/- hearts was markedly 
greater than those of WT animals (B). Unlike tissue slices, only marginal differences in ERP 
were observed in whole heart preparations (C). Asterisks indicate statistical significances from 
comparisons between Scn5a+/- and wild type (** p<0.01, ***p<0.001).  
 
Figure 4. The localisation of Cx43 in Scn5a+/- and wild type mice using laser scanning 
confocal microscopy. Representative heart sections are shown with N-cadherin staining 
marking the intercalated disc and DAPI the nucleus. Cx43 is expressed and present at the 
intercalated disc however there is an impression of mislocalisation of Cx43 away from the 
intercalated disc. This is confirmed using a numerical approach as detailed in the text. The 
sections are representative of a number of sections from a single mouse and the experiment 
was repeated in an additional littermate control and Scn5a+/- mouse (n=5 total sections in 
each group).  
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